TO: | Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health |
FROM: | John S O'Brien, Director, Legislative Budget Board |
IN RE: | HB2648 by Fletcher (Relating to the reestablishment of the Texas Bleeding Disorders Advisory Council.), As Introduced |
Fiscal Year | Probable Net Positive/(Negative) Impact to General Revenue Related Funds |
---|---|
2012 | ($192,967) |
2013 | ($67,059) |
2014 | ($192,059) |
2015 | ($67,059) |
2016 | $0 |
Fiscal Year | Probable Savings/(Cost) from General Revenue Fund 1 |
Change in Number of State Employees from FY 2011 |
---|---|---|
2012 | ($192,967) | 0.4 |
2013 | ($67,059) | 0.5 |
2014 | ($192,059) | 0.5 |
2015 | ($67,059) | 0.5 |
2016 | $0 | 0.0 |
In order to implement the provisions of the bill, the following assumptions are made:
1) 1/2 a full-time-equivalent (FTE) position - Program Specialist II is needed to coordinate Council activities and assist in the development of the reports. It is assumed that this individual would only be needed for nine months in the first year.
2) The cost for travel expenses for the 15 member board to meet quarterly for two day meetings is $24,420 a year. This includes airfare ($200), meals ($36 per day), ground transportation ($25 per day), and hotel ($85 per night).
3) $125,000 is needed in fiscal years 2012 and 2014 to conduct the hemophilia or other bleeding or clotting disorder studies required by the bill. It is assumed that these studies will be outsourced.
DSHS also assumes some small additional operating costs to implement the provisions in the bill.
Source Agencies: | 537 State Health Services, Department of
|
LBB Staff: | JOB, CL, MB, JF
|